Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shionogi (Pharmaceutical Brands)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Portfolio of four pharmaceutical brands. The portfolio includes four brand pharmaceutical products Triglide Tablets, Robinul and Robinul Forte Tablets, Furadantin Suspension and Fexmid Tablets.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Primary Office
  • 3-1-8 Doshomachi
  • Chuo-Ku
  • Osaka, 541-0045
  • Japan

Shionogi (Pharmaceutical Brands) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Shionogi (Pharmaceutical Brands)‘s full profile, request access.

Request full access to PitchBook

Shionogi (Pharmaceutical Brands) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Shionogi (Pharmaceutical Brands)‘s full profile, request access.

Request full access to PitchBook